Farmakoterapia w Psychiatrii i Neurologii

Pełna treść

2/2024 vol. 40
Artykuł oryginalny

Tolerancja aripiprazolu w populacji dziecięco-młodzieżowej i jej implikacje kliniczne

Anna Szmyt 1
,
Marta Szczygieł 1
,
Agnieszka Słopień 1
  1. Division of Child and Adolescent Psychiatry, Department of Psychiatry, Karol Marcinkowski University of Medical Sciences in Poznan, Poznań, Poland; Klinika Psychiatrii Dzieci i Młodzieży Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu, Polska
Farmakoterapia w Psychiatrii i Neurologii 2024, 40 (2), 83–93
DOI: https://doi.org/10.5114/fpn.2024.147493
Data publikacji online: 2025/03/31
Plik artykułu
1D0_IPiN_FARM_2024-2C.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Almandil NB, Liu Y, Murray ML, Besag FM, Aitchison KJ, Wong IC. Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis. Paediatr Drugs 2013; 15 (2): 139-150.
  2. Antosik-Wójcińska A. Arypiprazol – od wyników badań do zastosowania w praktyce klinicznej, Psychiatr Psychol Klin 2020; 20 (1): 66-70.
  3. Bernagie C, Danckaerts M, Wampers M et al. Aripiprazole and acute extrapyramidal symptoms in children and adolescents: a meta-analysis. CNS Drugs 2016; 30: 807-818.
  4. Cichoń L, Gabryel B, Jelonek I, Krysta K, Janas-Kozik M. The use of aripiprazole in the treatment of mental disorders in children and adolescents. Psychiatr Psychol Klin 2018,18 (4), 373-387.
  5. Findling RL, Robb A, Nyilas M, Forbes RA, Jin N, Ivanova S, et al. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. Am J Psychiatry 2008; 165 (11): 1432-1441.
  6. Gautam S, Jain A, Gautam M, Gautam A, Jagawat T. Clinical Practice Guidelines for Bipolar Affective Disorder (BPAD) in Children and Adolescents. Indian J Psychiatry 2019; 61 (Suppl 2): 294-305.
  7. Janas-Kozik M, Wolańczyk T. (redakcja naukowa). Psychiatria dzieci i młodzieży, tom 1 i 2. PZWL, Warszawa 2021.
  8. Jarema M. (redakcja naukowa). Standardy leczenia farmakologicznego niektórych zaburzeń psychicznych. Via Medica, Gdańsk 2015.
  9. Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D. et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013; 382 (9896): 951-962.
  10. Merino D, Gérard AO, Destere A, Saidessalam H, Askenazy F, et al. Cardiac and metabolic safety profile of antipsychotics in youths: A WHO safety database analysis. Psychiatry Res 2024; 334: 115786.
  11. Nowakowska K, Kaźmierski J. Arypiprazol – skuteczność i bezpieczeństwo terapii w codziennej praktyce. Psychiatr Psychol Klin 2019; 19 (4) : 442-449.
  12. Puzio D, Gmitrowicz A, Makowska I. Pharmacotherapy of challenging behaviours in children and adolescents with autism spectrum disorder. Advances in Psychiatry and Neurology 2019; 28 (2): 145-153.
  13. Robb AS, Andersson C, Bellocchio EE, Manos G, Rojas-Fernandez C, et al. Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old): results from a pooled analysis of 2 studies. Prim Care Companion CNS Disord 2011; 13 (1).
  14. Rybakowski J (redakcja naukowa). Psychofarmakologia Kliniczna. PZWL, Warszawa 2022.
  15. Solmi M, Fornaro M, Ostinelli EG, Zangani C, Croatto G, et al. Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects. World Psychiatry 2020; 19 (2): 214-232.
  16. Solmi M, Murru A, Pacchiarotti I et al. Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review. Ther Clin Risk Manag 2017; 13: 757-777.
  17. Yang CS, Huang H, Zhang LL, Zhu CR, Guo Q. Aripiprazole for the treatment of tic disorders in children: a systematic review and meta-analysis. BMC Psychiatry 2015; 15: 1792015.
ZGŁASZANIE PRAC
Udostępnij
without publication fees
without publication fees
Zintergrowane z
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications